EBUS-TBNA vs PET for Lung Cancer Diagnosis in TB-Endemic Areas
Author Information
Author(s): Kuo Chih-Hsi, Chen Hao-Cheng, Chung Fu-Tsai, Lo Yu-Lun, Lee Kang-Yun, Wang Chih-Wei, Kuo Wen-Han, Yen Tzu-Chen, Kuo Han-Pin
Primary Institution: Chang Gung Memorial Hospital, Chang Gung University School of Medicine, Taipei, Taiwan
Hypothesis
This study aimed to compare the accuracy of nodal diagnosis by using EBUS-TBNA and PET in lung cancer patients with non-enlarged lymph nodes.
Conclusion
EBUS-TBNA is preferred over PET for nodal staging in lung cancer patients in TB-endemic areas due to its higher diagnostic accuracy.
Supporting Evidence
- EBUS-TBNA had a sensitivity of 80.6% and specificity of 100%.
- PET had low specificity (18.9%) and a low positive predictive value (44.4%).
- The diagnostic accuracy of EBUS-TBNA was 91%, compared to 47.4% for PET.
- Patients with negative PET diagnostic impact had a high incidence of previous pulmonary TB.
- Multivariate analysis indicated that detection of hilar nodes on PET was an independent predictor of negative diagnostic impact.
Takeaway
Doctors used a special needle to take samples from lymph nodes in lung cancer patients, and found that this method works better than a scan that looks for cancer.
Methodology
The study involved 43 lung cancer patients with non-enlarged lymph nodes, using EBUS-TBNA to sample 78 lymph nodes and comparing results with PET scans.
Potential Biases
Potential bias due to the high rate of false-positive results from PET in patients with previous pulmonary TB.
Limitations
The study was limited by the small sample size and the use of older PET technology.
Participant Demographics
43 lung cancer patients (25 men, 18 women; median age: 66 years).
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 1.32–25.11
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website